Covid-19 manufacturing roundup: Germany locks in vaccine supply until 2029; White House announces vaccine donation milestone
Germany’s cabinet has approved a plan to spend $3.14 billion to ensure BioNTech, CureVac/GSK, CordenPharma and other vaccine manufactures have the production capacity to supply the country with enough Covid-19 vaccines for future outbreaks through 2029.
The contracts will keep up the increased production capabilities, Reuters reported Wednesday. An annual standby fee will help ensure that enough vaccine can be produced quickly, if needed. They also give the government the right to access production capacities if a new pandemic breaks out.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.